Bennett Watson | Investor Relations, ICR Westwicke |
Dan Barber | Chief Executive Officer |
Ernie Toth | Senior Vice President, Chief Financial Officer |
Steve Wargacki | Senior Vice President, Research and Development |
Ken Marshall | Senior Vice President, Chief Commercial Officer |
Jason Butler | JMP Securities |
Francois Brisebois | Oppenheimer |
Thomas Flaten | Lake Street Capital Markets |
Caroline Pocher | Wedbush Securities |
Raghuram Selvaraju | H.C. Wainwright & Company |
Good morning and welcome to the Aquestive Therapeutics First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, this call will be recorded.
And I would now like to introduce your host for today's conference call, Bennett Watson of ICR Westwicke, Investor Relations.